Logo image of SAE.DE

SHOP APOTHEKE EUROPE NV (SAE.DE) Stock Fundamental Analysis

FRA:SAE - Deutsche Boerse Ag - NL0012044747 - Common Stock - Currency: EUR

88.3  -0.58 (-0.65%)

Fundamental Rating

4

SAE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 26 industry peers in the Consumer Staples Distribution & Retail industry. SAE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SAE is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SAE has reported negative net income.
SAE had a negative operating cash flow in the past year.
In the past 5 years SAE always reported negative net income.
In multiple years SAE reported negative operating cash flow during the last 5 years.
SAE.DE Yearly Net Income VS EBIT VS OCF VS FCFSAE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -20M -40M -60M -80M

1.2 Ratios

SAE has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SAE.DE Yearly ROA, ROE, ROICSAE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 -100 -200 -300 -400

1.3 Margins

With an excellent Gross Margin value of 27.83%, SAE belongs to the best of the industry, outperforming 81.48% of the companies in the same industry.
In the last couple of years the Gross Margin of SAE has grown nicely.
The Profit Margin and Operating Margin are not available for SAE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.94%
GM growth 5Y6.32%
SAE.DE Yearly Profit, Operating, Gross MarginsSAE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20

More info and screens

5

2. Health

2.1 Basic Checks

SAE does not have a ROIC to compare to the WACC, probably because it is not profitable.
SAE has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, SAE has a worse debt to assets ratio.
SAE.DE Yearly Shares OutstandingSAE.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M
SAE.DE Yearly Total Debt VS Total AssetsSAE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M

2.2 Solvency

SAE has an Altman-Z score of 3.78. This indicates that SAE is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.78, SAE belongs to the top of the industry, outperforming 81.48% of the companies in the same industry.
SAE has a Debt/Equity ratio of 0.72. This is a neutral value indicating SAE is somewhat dependend on debt financing.
SAE has a better Debt to Equity ratio (0.72) than 70.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Altman-Z 3.78
ROIC/WACCN/A
WACC6.74%
SAE.DE Yearly LT Debt VS Equity VS FCFSAE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 2.39 indicates that SAE has no problem at all paying its short term obligations.
SAE has a better Current ratio (2.39) than 96.30% of its industry peers.
SAE has a Quick Ratio of 1.77. This is a normal value and indicates that SAE is financially healthy and should not expect problems in meeting its short term obligations.
SAE has a Quick ratio of 1.77. This is amongst the best in the industry. SAE outperforms 96.30% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.77
SAE.DE Yearly Current Assets VS Current LiabilitesSAE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

SAE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.57%, which is quite impressive.
Looking at the last year, SAE shows a quite strong growth in Revenue. The Revenue has grown by 17.63% in the last year.
SAE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.50% yearly.
EPS 1Y (TTM)29.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.74%
Revenue 1Y (TTM)17.63%
Revenue growth 3Y19.77%
Revenue growth 5Y33.5%
Sales Q2Q%22.07%

3.2 Future

Based on estimates for the next years, SAE will show a very strong growth in Earnings Per Share. The EPS will grow by 28.99% on average per year.
Based on estimates for the next years, SAE will show a very strong growth in Revenue. The Revenue will grow by 24.47% on average per year.
EPS Next Y46.26%
EPS Next 2Y38.43%
EPS Next 3Y32.71%
EPS Next 5Y28.99%
Revenue Next Year21.52%
Revenue Next 2Y22.74%
Revenue Next 3Y22.49%
Revenue Next 5Y24.47%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SAE.DE Yearly Revenue VS EstimatesSAE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
SAE.DE Yearly EPS VS EstimatesSAE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SAE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SAE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SAE.DE Price Earnings VS Forward Price EarningsSAE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200 -250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SAE.DE Per share dataSAE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

SAE's earnings are expected to grow with 32.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.43%
EPS Next 3Y32.71%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SAE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SHOP APOTHEKE EUROPE NV

FRA:SAE (6/12/2023, 7:00:00 PM)

88.3

-0.58 (-0.65%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.63B
Analysts73.33
Price Target95.37 (8.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.57%
PT rev (3m)22.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)18.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.28
P/FCF N/A
P/OCF N/A
P/B 4.68
P/tB 27.79
EV/EBITDA N/A
EPS(TTM)-3.57
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-3.21
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS69.01
BVpS18.85
TBVpS3.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.83%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.94%
GM growth 5Y6.32%
F-Score3
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 116.92%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.39
Quick Ratio 1.77
Altman-Z 3.78
F-Score3
WACC6.74%
ROIC/WACCN/A
Cap/Depr(3y)209.18%
Cap/Depr(5y)163.35%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.74%
EPS Next Y46.26%
EPS Next 2Y38.43%
EPS Next 3Y32.71%
EPS Next 5Y28.99%
Revenue 1Y (TTM)17.63%
Revenue growth 3Y19.77%
Revenue growth 5Y33.5%
Sales Q2Q%22.07%
Revenue Next Year21.52%
Revenue Next 2Y22.74%
Revenue Next 3Y22.49%
Revenue Next 5Y24.47%
EBIT growth 1Y7.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year130.3%
EBIT Next 3Y51.27%
EBIT Next 5Y41.47%
FCF growth 1Y-239.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-125.26%
OCF growth 3YN/A
OCF growth 5YN/A